PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Total flavonoids from J. sabina significantly inhibited xylene-induced ear edema and ameliorated paw swelling and arthritic scores in rat models [PMID:30069226, PMID:27601846].
Essential oil of J. sabina demonstrated a protective effect against CCl4 induced toxicity in male Wistar rats [PMID:31997901].
Leaf and fruit extracts showed inhibitory activity on alpha-glucosidase and alpha-amylase enzymes and demonstrated antidiabetic activity in streptozotocin-induced diabetic rats [PMID:29844777].
Cupressuflavone (CUP) administered to rats reduced brain ischemia/reperfusion damage [PMID:38204594].
Ethanolic extracts of J. sabina provided protection against barium chloride-induced arrhythmia in a mouse model [PMID:39204108].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 39769965 (2024) — Phytochemistry, Pharmacology, and Traditional Medicine Applications of Juniperus sabina L.: A Comprehensive Overview. · Molecules (Basel, Switzerland)
- 2.PMID: 33756015 (2021) — Leaf morphology, photosynthesis and pigments change with age and light regime in savin juniper. · Plant biology (Stuttgart, Germany)
- 3.PMID: 36142118 (2022) — Juniperus sabina L. as a Source of Podophyllotoxins: Extraction Optimization and Anticholinesterase Activities. · International journal of molecular sciences
- 4.PMID: 36426016 (2022) — The complete chloroplast genome sequencing data of Juniperus sabina L. (Cupressaceae Bartl.) from Kazakhstan. · Data in brief
- 5.PMID: 37731973 (2023)